Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Intact Genomics
company
About
Intact Genomics provides high-quality life science products and large DNA fragment cloning related services
- 1 - 10
Details
- Last Funding Type
- Grant
- Industries
- Biopharma,Biotechnology,Clinical Trials,Health Care,Medical Device
- Founded date
- Jan 1, 2013
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Intact Genomics is a world leader in large DNA fragment cloning and metagenomic technologies. We have dedicated scientists and state of the art equipment all housed in a modern facility, located in the Helix Center Biotech Incubator, next to Monsanto Headquarters, Donald Danforth Plant Science Center, and close to Washington University in St. Louis
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$1.50M
Intact Genomics has raised a total of
$1.50M
in funding over 2 rounds. Their latest funding was raised on
Jun 1, 2018 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 1, 2018 | Grant | $1.50M | 1 |
National Institutes of Health
|
— | Detail |
| Jul 12, 2016 | Grant | — | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
1
Intact Genomics is funded by 1 investors.
National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
